• 1. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 2. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 3. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 4. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 5. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291

Comprehensive Overview of 6,2',3'-Trifluorobiphenyl-2-acetic acid (CAS No. 1261485-94-2): Properties, Applications, and Industry Insights

6,2',3'-Trifluorobiphenyl-2-acetic acid (CAS No. 1261485-94-2) is a fluorinated biphenyl derivative that has garnered significant attention in pharmaceutical and agrochemical research due to its unique structural features. The compound's trifluorobiphenyl core, combined with an acetic acid functional group, makes it a versatile intermediate for synthesizing bioactive molecules. Researchers are increasingly exploring its potential in drug discovery, particularly in targeting inflammation and metabolic disorders, aligning with the growing demand for fluorinated pharmaceuticals.

The rise of precision medicine and targeted therapies has amplified interest in fluorinated compounds like 6,2',3'-Trifluorobiphenyl-2-acetic acid. Fluorine atoms enhance metabolic stability and bioavailability, addressing common challenges in drug development. Recent studies highlight its role in modulating enzyme activity, making it relevant to cancer research and autoimmune disease treatments—topics frequently searched in academic and industry circles.

From a synthetic chemistry perspective, the compound's fluorine substitution pattern offers steric and electronic advantages. Its 2,2',3'-trifluoro configuration influences π-stacking interactions, a hot topic in computational chemistry forums. This property is leveraged in designing high-performance materials, such as liquid crystals for displays—a sector experiencing rapid growth due to demand for flexible electronics.

Environmental considerations are paramount in modern chemical applications. 6,2',3'-Trifluorobiphenyl-2-acetic acid exhibits improved biodegradability compared to legacy polyfluorinated compounds, addressing green chemistry priorities. Regulatory trends like the EU's Chemical Strategy for Sustainability have spurred searches for eco-friendly fluorochemicals, positioning this compound as a candidate for sustainable innovation.

Analytical characterization of CAS 1261485-94-2 involves advanced techniques like 19F-NMR and LC-MS, reflecting industry shifts toward high-resolution analytics. These methods are crucial for quality control in contract manufacturing organizations (CMOs), a rapidly expanding market segment. The compound's clear spectral signatures facilitate its adoption in high-throughput screening workflows.

Market projections indicate robust growth for fluorinated building blocks, with 6,2',3'-Trifluorobiphenyl-2-acetic acid benefiting from trends in personalized medicine and crop protection. Patent analyses reveal increasing filings incorporating this scaffold, particularly in kinase inhibitor development—a response to oncology market demands. These insights make the compound a strategic focus for fine chemical suppliers.

Handling and storage recommendations for 1261485-94-2 follow standard protocols for carboxylic acids, with emphasis on moisture-sensitive conditions. Its thermal stability data (typically stable to 150°C) supports applications in high-temperature reactions, a frequent query among process chemists optimizing scale-up protocols.

Emerging applications in PET radiopharmaceuticals utilize fluorine-rich compounds like this as precursors for 18F-labeling. This connects to trending searches about diagnostic imaging advancements. Additionally, its potential in ionic liquid formulations for battery electrolytes aligns with renewable energy research priorities.

Comparative studies with analogous difluorobiphenyl derivatives demonstrate how the third fluorine in 6,2',3'-Trifluorobiphenyl-2-acetic acid enhances lipophilicity parameters—critical for blood-brain barrier penetration studies. Such structure-activity relationship (SAR) data is highly valued in medicinal chemistry communities.

In conclusion, 6,2',3'-Trifluorobiphenyl-2-acetic acid represents a multifaceted compound bridging pharmaceutical innovation and material science. Its CAS registry (1261485-94-2) serves as a key identifier for researchers exploring fluorine chemistry applications across therapeutic, diagnostic, and advanced material domains.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)